相似文献
1
Activation of the Pseudomonas aeruginosa type III secretion system requires an intact pyruvate dehydrogenase aceAB operon.
Infect Immun. 2002 Jul;70(7):3973-7. doi: 10.1128/IAI.70.7.3973-3977.2002.
2
Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates.
Infect Immun. 2001 Jan;69(1):538-42. doi: 10.1128/IAI.69.1.538-542.2001.
3
A novel sensor kinase-response regulator hybrid regulates type III secretion and is required for virulence in Pseudomonas aeruginosa.
Mol Microbiol. 2004 Nov;54(4):1090-103. doi: 10.1111/j.1365-2958.2004.04331.x.
4
Type III secretion-dependent modulation of innate immunity as one of multiple factors regulated by Pseudomonas aeruginosa RetS.
Infect Immun. 2006 Jul;74(7):3880-9. doi: 10.1128/IAI.01891-05.
5
Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.
Microbiology (Reading). 2001 Oct;147(Pt 10):2659-2669. doi: 10.1099/00221287-147-10-2659.
6
An adenylate cyclase-controlled signaling network regulates Pseudomonas aeruginosa virulence in a mouse model of acute pneumonia.
Infect Immun. 2004 Mar;72(3):1677-84. doi: 10.1128/IAI.72.3.1677-1684.2004.
7
ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
Mol Microbiol. 1997 Aug;25(3):547-57. doi: 10.1046/j.1365-2958.1997.4891851.x.
8
PsrA is a positive transcriptional regulator of the type III secretion system in Pseudomonas aeruginosa.
Infect Immun. 2006 Feb;74(2):1121-9. doi: 10.1128/IAI.74.2.1121-1129.2006.
9
Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system.
Infect Immun. 2005 Jul;73(7):4263-71. doi: 10.1128/IAI.73.7.4263-4271.2005.
10
Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.
Infect Immun. 2000 May;68(5):2916-24. doi: 10.1128/IAI.68.5.2916-2924.2000.
引用本文的文献
1
Metabolic specialization drives reduced pathogenicity in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
PLoS Biol. 2024 Aug 23;22(8):e3002781. doi: 10.1371/journal.pbio.3002781. eCollection 2024 Aug.
2
Virulence and Metabolism Crosstalk: Impaired Activity of the Type Three Secretion System (T3SS) in a Crc-Defective Mutant.
Int J Mol Sci. 2023 Aug 1;24(15):12304. doi: 10.3390/ijms241512304.
3
TpiA is a Key Metabolic Enzyme That Affects Virulence and Resistance to Aminoglycoside Antibiotics through CrcZ in Pseudomonas aeruginosa.
mBio. 2020 Jan 7;11(1):e02079-19. doi: 10.1128/mBio.02079-19.
4
Tricarboxylic Acid (TCA) Cycle Enzymes and Intermediates Modulate Intracellular Cyclic di-GMP Levels and the Production of Plant Cell Wall-Degrading Enzymes in Soft Rot Pathogen .
Mol Plant Microbe Interact. 2020 Feb;33(2):296-307. doi: 10.1094/MPMI-07-19-0203-R. Epub 2019 Dec 18.
5
Dynamic Relay of Protein-Bound Lipoic Acid in Staphylococcus aureus.
J Bacteriol. 2019 Oct 21;201(22). doi: 10.1128/JB.00446-19. Print 2019 Nov 15.
6
Increased flexibility in the use of exogenous lipoic acid by Staphylococcus aureus.
Mol Microbiol. 2018 Jul;109(2):150-168. doi: 10.1111/mmi.13970. Epub 2018 May 3.
7
Structural and functional insights into the periplasmic detector domain of the GacS histidine kinase controlling biofilm formation in Pseudomonas aeruginosa.
Sci Rep. 2017 Sep 12;7(1):11262. doi: 10.1038/s41598-017-11361-3.
8
Fragment library screening identifies hits that bind to the non-catalytic surface of Pseudomonas aeruginosa DsbA1.
PLoS One. 2017 Mar 27;12(3):e0173436. doi: 10.1371/journal.pone.0173436. eCollection 2017.
9
Staphylococcus aureus Tissue Infection During Sepsis Is Supported by Differential Use of Bacterial or Host-Derived Lipoic Acid.
PLoS Pathog. 2016 Oct 4;12(10):e1005933. doi: 10.1371/journal.ppat.1005933. eCollection 2016 Oct.
10
Modulation of Type III Secretion System in Pseudomonas aeruginosa: Involvement of the PA4857 Gene Product.
Front Microbiol. 2016 Jan 28;7:7. doi: 10.3389/fmicb.2016.00007. eCollection 2016.
本文引用的文献
1
Acetylornithinase of Escherichia coli: partial purification and some properties.
J Biol Chem. 1956 Jan;218(1):97-106.
2
Pore-forming activity of type III system-secreted proteins leads to oncosis of Pseudomonas aeruginosa-infected macrophages.
Mol Microbiol. 2001 Apr;40(1):76-85. doi: 10.1046/j.1365-2958.2001.02368.x.
3
Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates.
Infect Immun. 2001 Jan;69(1):538-42. doi: 10.1128/IAI.69.1.538-542.2001.
4
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.
Nature. 2000 Aug 31;406(6799):959-64. doi: 10.1038/35023079.
5
Periplasmic protein thiol:disulfide oxidoreductases of Escherichia coli.
FEMS Microbiol Rev. 2000 Jul;24(3):303-16. doi: 10.1111/j.1574-6976.2000.tb00544.x.
6
Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.
Infect Immun. 2000 May;68(5):2916-24. doi: 10.1128/IAI.68.5.2916-2924.2000.
7
Inorganic polyphosphate is needed for swimming, swarming, and twitching motilities of Pseudomonas aeruginosa.
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4885-90. doi: 10.1073/pnas.060030097.
8
Pathogenicity of microbes associated with cystic fibrosis.
Microbes Infect. 1999 Oct;1(12):1005-14. doi: 10.1016/s1286-4579(99)80518-8.
9
In Azotobacter vinelandii, the E1 subunit of the pyruvate dehydrogenase complex binds fpr promoter region DNA and ferredoxin I.
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12389-93. doi: 10.1073/pnas.96.22.12389.
10
Cell death of human polymorphonuclear neutrophils induced by a Pseudomonas aeruginosa cystic fibrosis isolate requires a functional type III secretion system.
Infect Immun. 1999 Nov;67(11):6164-7. doi: 10.1128/IAI.67.11.6164-6167.1999.
Zotero 插件